HIPAA -- Part I: Privacy Takes Center Stage

March 11, 2010 | LOGIN | REGISTER | HELP |

Direct-To-Consumer Genetic Testing The Genetic Information Nondiscrimination Act (GINA): What It Does and Does
Not Do and What It Means for Health Care Professionals Medical Research Ethics: Standards and Issues The Dark Side of Public Health The Truth About Medical Malpractice Consumer-Driven Health Care: Ethical and Legal Pitfalls The Ethics of Embryonic Stem Cell Research Striking Back Off-Label Prescribing Performance Enhancing Drugs in Sports Legal and Ethical Challenges in Clinical Use of Complementary and
Alternative Medicine Risky Doctors: Should Professionals Inform Patients?HIPAA -- Part II: The Big Print and the Little Print HIPAA -- Part I: Privacy Takes Center Stage Should Providers Be Liable for Wrongful Prolongation of Life?A Potentially Serious Threat to the Use of Practice Guidelines to Help
Establish the Standard of Care "I'm Sorry," But You Still May Be Liable Patient Protections and the Supreme Court The 2000 Presidential Race - Where the Candidates Stand on Health Care
Issues Medical Mistakes: Did the IOM Get It Right?

Moderator's Bio Other Specialties Corrections Discuss

CME credit is no longer available for this conference.

Ilise L. Feitshans, J.D., Sc.M.

Ms. Feitshans is Adjunct Associate Professor, George Washington University School of Public Health and Health Services, Washington D.C., and Legal Advisor, WHO/RAMS Committee of Experts on Reproductive Health at Work. She reports no conflict of interest.

Release Date: 04/29/2003
Termination Date: 04/29/2006

Estimated time to complete: 1 hour(s).

Albert Einstein College of Medicine designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Educational Objectives

Discuss implementation of new 2003 HIPAA regulations for medical privacy
Discuss the significance of preventing unauthorized disclosure of personal medical information
Describe at least 5 basic components of an in-house compliance system that secures protected health information (PHI).

The information contained and displayed in this communication and within this Web site is provided solely for educational and discussion purposes. It does not constitute legal advice. No attorney-client relationship is formed by the transmission or receipt of this communication. No warranty, express or implied, is being offered. The actual law in the member-subscriber's jurisdiction may differ from that which is described in this communication. The member-subscriber should seek legal advice from his or her attorney on any matters related to the subject matter of this communication.

This conference may include discussion of commercial products and services.

The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.

Health Law Disclaimer

Please click below to accept the terms of this CME activity